Literature DB >> 2479643

The acquisition of increased insulin-responsive hexose transport in 3T3-L1 adipocytes correlates with expression of a novel transporter gene.

A Garcia de Herreros1, M J Birnbaum.   

Abstract

The expression of two genes encoding facilitated glucose transporter proteins was studied during the differentiation of the 3T3-L1 fibroblastic cell line into adipocytes. The mRNA encoding the widely expressed HepG2/brain glucose transporter (GTI) is detectable in fibroblasts and its abundance remains unchanged during differentiation. On the other hand, the mRNA encoding a glucose transporter protein (GTIII) localized exclusively to muscle and adipose tissue is undetectable in fibroblasts but present in adipocytes. GTIII mRNA is first expressed three days after differentiation of 3T3-L1 cells has begun. Similarly, it is not until 3 days following the initiation of differentiation that GTIII protein can be detected, as assayed either by Western immunoblot or indirect immunofluorescence. The latter technique localizes GTIII predominantly to the perinuclear region of the adipocyte. The appearance of GTIII in developing fat cells correlates temporally with the acquisition of an increased stimulation of hexose uptake by maximal concentrations of insulin. These data support the concept that the marked increase in hexose transport in adipocytes in response to insulin is dependent on the expression in these cells of a specific, hormone-regulatable transport protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479643

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination.

Authors:  D Accili; S I Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Cloning of a Rab3 isotype predominantly expressed in adipocytes.

Authors:  G Baldini; T Hohl; H Y Lin; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Hexose specificity for downregulation of HepG2/brain-type glucose transporter gene expression in L6 myocytes.

Authors:  F Maher; L C Harrison
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

4.  Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.

Authors:  P Peraldi; M Xu; B M Spiegelman
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

5.  GTPase activating protein activity for Rab4 is enriched in the plasma membrane of 3T3-L1 adipocytes. Possible involvement in the regulation of Rab4 subcellular localization.

Authors:  M N Bortoluzzi; M Cormont; N Gautier; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

6.  PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes.

Authors:  Z Wu; Y Xie; R F Morrison; N L Bucher; S R Farmer
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes.

Authors:  V Ribon; J A Printen; N G Hoffman; B K Kay; A R Saltiel
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 8.  Thirty sweet years of GLUT4.

Authors:  Amira Klip; Timothy E McGraw; David E James
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

9.  New insights into cytosolic glucose levels during differentiation of 3T3-L1 fibroblasts into adipocytes.

Authors:  Petra Brina Kovacic; Helena H Chowdhury; Jelena Velebit; Marko Kreft; Jørgen Jensen; Robert Zorec
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

10.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Authors:  G S Hotamisligil; D L Murray; L N Choy; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.